WO2026069069 - ORODISPERSIBLE TABLET COMPOSITION CONTAINING CARBIDOPA AND LEVODOPA
National phase entry is expected:
Publication Number
WO/2026/069069
Publication Date
02.04.2026
International Application No.
PCT/IB2025/059292
International Filing Date
17.09.2025
Title **
[English]
ORODISPERSIBLE TABLET COMPOSITION CONTAINING CARBIDOPA AND LEVODOPA
[French]
COMPOSITION DE COMPRIMÉ ORODISPERSIBLE CONTENANT DE LA CARBIDOPA ET DE LA LÉVODOPA
Applicants **
NOVUMGEN LIMITED
Inventors
PATEL, Kamleshkumar
Priority Data
2414041.0
24.09.2024
GB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2314 | |
| EPO | Filing, Examination, Granting | 13324 | |
| Japan | Filing, Examination, Granting | 2487 | |
| South Korea | Filing, Examination, Granting | 2669 | |
| USA | Filing, Examination, Granting | 5740 |
Total:
26,534
Contact Us
Abstract[English]
The present invention relates to a solid pharmaceutical composition manufactured by a wet granulation method comprising carbidopa and levodopa or pharmaceutically acceptable salts thereof, one or more disintegrant, one or more diluent, at least one binder, at least one lubricant, and one or more pharmaceutically acceptable excipients. The orodispersible tablet prepared using these excipients exhibits desirable properties such as facilitating disintegration, and dissolution of the drug for oral administration. Further, the present invention also relates to the process for preparing the said solid pharmaceutical composition.[French]
La présente invention concerne une composition pharmaceutique solide fabriquée par un procédé de granulation par voie humide comprenant de la carbidopa et de la lévodopa ou des sels pharmaceutiquement acceptables de celles-ci, un ou plusieurs agents désagrégeants, un ou plusieurs diluants, au moins un liant, au moins un lubrifiant et un ou plusieurs excipients pharmaceutiquement acceptables. Le comprimé orodispersible préparé à l'aide de ces excipients présente des propriétés souhaitables telles qu'une désagrégation améliorée, et une dissolution améliorée du médicament par administration orale. En outre, la présente invention concerne également le procédé de préparation de ladite composition pharmaceutique solide.